Thermo Fisher Scientific launches RNAi services laboratory
Thermo Fisher Scientific has opened a new RNAi Discovery and Therapeutics Services Laboratory to help pharmaceutical companies in their quest for new drugs.
Archives for June 20, 2007
Greenovation receives first US patent for moss technology
German biotech company, Greenovation has received a broad ranging US patent for its unique moss-based biopharmaceutical production technology.
Shire snaps up new ADHD patch
Shire Pharmaceuticals has acquired exclusive development rights to a new transdermal patch product for Attention-Deficit/Hyperactivity Disorder (ADHD), adding a further novel product to its ADHD portfolio.
Finnish CRO dives into metabolomics sea
Finnish CRO Technical Research Center (VTT) has spun-off Zora Biosciences, which becomes the only company in the Nordic region to provide metabolomics services to pharma companies - a market with high potential.
Ex Cardinal Health contract biz reborn as Catalent
The contract manufacturing business that Cardinal Health sold earlier this year has just been launched as an independent operating company rebranded as Catalent Pharma Solutions.
ISPE releases revamped API guide
The International Society for Pharmaceutical Engineering (ISPE) has published its latest industry guide, a revised edition of its manual providing industry guidance on facilities and production of active pharmaceutical ingredients (APIs).
Fluidigm miniaturises the time and cost of PCR genotyping
US-microfluidics expert Fluidigm has launched a new dynamic array for its BioMark instrument that increases the efficiency of PCR (polymerase chain reaction) genotyping while reducing the amount of costly equipment and reagents needed.
Disposables crucial in future of patient-specific meds
At a time when single-use manufacturing equipment is riding on a surge of popularity, in-PharmaTechnologist.com talks to Vijay Singh of GE Healthcare's newly acquired Wave Biotech unit about the impact disposables will have on the future of...
Novartis' combo hypertension drug approved in US
Novartis' has received US approval for its single-tablet combination of the world's two most popular hypertension drugs, taking advantage of rival patent expiries and shoring up its portfolio.